Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

US Dental Bone Grafts and Substitutes Key Players-Business, Deal & Patent Strategies

Date : 24 June 2026

Who are the Market's Top Companies, and What are Their Offerings?

U.S. Dental Bone Grafts and Substitutes Market Companies are ZimVie Inc., LifeNet Health, Dentsply Sirona Inc., Medtronic plc, BioHorizons, Collagen Matrix, Inc., Geistlich Pharma North America

Recent Developments in the Market

  • In November 2025, nanOss Strata, the next-generation innovative synthetic bone graft in the nanOss line, was launched by Xtant Medical Holdings. The product offers enhanced solubility, improving the bioactivity of the graft, better integration, and remodeling with the surrounding bone tissue.
  • In February 2025, OraGen®, the first viable dental bone allograft, was launched by LifeNet Health, which consists of endogenous lineage-committed bone cells combined with demineralized bone matrix. The product will offer three essential properties for bone regeneration, that is, osteogenicity, osteoconductivity, and osteoinduction for new bone production, cell attachment and growth, and stimulate bone repair, respectively.

Market Ecosystem Analysis

Ecosystem Segment Description Key Participants
Technology Providers Develop regenerative biomaterials, collagen matrices, synthetic graft technologies, growth-factor platforms Geistlich Pharma, ZimVie, NovaBone, botiss
Product Manufacturers Produce dental bone graft materials, membranes, allografts, xenografts, synthetic substitutes Dentsply Sirona, Straumann, Envista/Nobel Biocare, BioHorizons
Service Providers Clinical training, implant planning, regenerative procedure support Straumann, Dentsply Sirona, BioHorizons
Platform Providers Integrated implant + regenerative dentistry ecosystems Straumann, Envista, Dentsply Sirona, ZimVie
Tissue Banks / Biologic Suppliers Human tissue-derived allograft manufacturers LifeNet Health, MTF Biologics
Software Vendors Digital implant planning and guided surgery platforms Dentsply Sirona, Straumann, Envista
Research Institutions Regenerative dentistry research and clinical validation Harvard School of Dental Medicine, University of Michigan School of Dentistry, University of Pennsylvania School of Dental Medicine
End-User Industries Dental care delivery organizations utilizing graft products Dental clinics, DSOs, hospitals, oral surgery centers

Market Value Chain Analysis

R&D

  • The R&D of the U.S. dental bone grafts and substitutes focuses on developing custom 3D-printed scaffolds, sugar-crosslinked collagen frameworks, and advanced biomimetic synthetics.
  • Key players: Geistlich Pharma North America, Dentsply Sirona Inc., and ZimVie Inc.

Clinical Trials and Regulatory Approvals

  • The biocompatibility, new bone formation, mechanical handling, and volumetric structural stability are evaluated in the clinical trials, and regulatory approvals of the dental bone grafts and substitutes in the U.S.
  • Key players: Geistlich Pharma North America, Dentsply Sirona Inc., and ZimVie Inc.

Patient Support and Services

  • The specialist provider networks, digital patient-education materials, and procedure tracking guides are provided in the patient support and services of the dental bone grafts and substitutes in the U.S.
  • Key players: Geistlich Pharma North America, Medtronic plc, and ZimVie Inc.

Competitive Landscape

Tier 1
Company Name Headquarters Country Why Relevant to This Market Key Products/Services Related to Keyword
Dentsply Sirona Charlotte, North Carolina USA Leading regenerative dentistry supplier with extensive implant and graft portfolio Symbios bone grafts, regenerative biomaterials, GBR solutions
Geistlich Pharma Wolhusen, Lucerne Switzerland Gold-standard regenerative biomaterials widely used in implant dentistry Bio-Oss®, Bio-Gide®, regenerative biomaterials
Institut Straumann AG Basel Switzerland Major implantology and regenerative dentistry leader Straumann Biomaterials, botiss portfolio, regenerative solutions
ZimVie Palm Beach Gardens, Florida USA Strong U.S. implant and bone regeneration presence RegenerOss product family, allografts, xenografts
Envista Holdings Brea, California USA Nobel Biocare regenerative portfolio integrated with implant business Creos™ grafting solutions, membranes, regenerative products
Tier 2
Company Name Headquarters Country Why Relevant to This Market Key Products/Services Related to Keyword
BioHorizons Birmingham, Alabama USA Significant implant and regenerative dentistry participant MinerOss®, Mem-Lok®, grafting materials
LifeNet Health Virginia Beach, Virginia USA Major allograft supplier with dedicated dental portfolio OraGraft®, OraGen®, dental allografts
Dentium USA Cypress, California USA Growing U.S. implant and graft materials supplier OSTEON graft products, regenerative solutions
Implant Direct Thousand Oaks, California USA Strong implant-focused regenerative product offering Allografts, membranes, grafting products
botiss biomaterials Berlin Germany Specialized regenerative biomaterials leader cerabone®, maxgraft®, collagen products
Tier 3
Company Name Headquarters Country Why Relevant to This Market Key Products/Services Related to Keyword
NovaBone Alachua, Florida USA Specialized synthetic bone graft developer NovaBone Dental Putty, bioactive glass grafts
Osteogenics Biomedical Lubbock, Texas USA Focused regenerative dentistry company Cytoplast™ membranes and grafting products
SigmaGraft Fullerton, California USA Specialized dental graft biomaterials provider Synthetic and allograft biomaterials
MTF Biologics Edison, New Jersey USA Leading tissue-bank organization supplying dental allografts DBM and dental regenerative allografts
Avtec Surgical Louisville, Kentucky USA Niche regenerative biomaterials supplier active in U.S. dental market Dental bone graft substitutes and membranes

Market Growth

The U.S. dental bone grafts and substitutes market size was estimated at USD 285 million in 2025 and is predicted to increase from USD 307.23 million in 2026 to approximately USD 603.99 million by 2035, expanding at a CAGR of 7.8% from 2026 to 2035.

U.S. Dental Bone Grafts and Substitutes Market Size is USD 307.23 Million in 2026.

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales